Johns Hopkins University

Johns Hopkins University

Introduction

Johns Hopkins University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Johns Hopkins University (JHU), founded in 1876, is one of the world's leading research universities and a major center for neurodegenerative disease research. Located in Baltimore, Maryland, the university has been at the forefront of neuroscience research for over a century. The Johns Hopkins Alzheimer's Disease Research Center (ADRC), established in 1984, is one of the original NIH-funded Alzheimer's Disease Research Centers, and the Morris K. Udall Centers of Excellence for Parkinson's Disease Research represent cornerstone programs in understanding and treating these devastating disorders. [@singleton2003]

Overview

...

Johns Hopkins University

Introduction

Johns Hopkins University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Johns Hopkins University (JHU), founded in 1876, is one of the world's leading research universities and a major center for neurodegenerative disease research. Located in Baltimore, Maryland, the university has been at the forefront of neuroscience research for over a century. The Johns Hopkins Alzheimer's Disease Research Center (ADRC), established in 1984, is one of the original NIH-funded Alzheimer's Disease Research Centers, and the Morris K. Udall Centers of Excellence for Parkinson's Disease Research represent cornerstone programs in understanding and treating these devastating disorders. [@singleton2003]

Overview

| Attribute | Details | [@rebeck2018]
|-----------|---------| [@moghekar2012]
| Full Name | Johns Hopkins University | [@guerreiro2013]
| Location | Baltimore, Maryland, USA | [@chenplotkin2018]
| Type | Private Research University | [@alzheimers2020]
| Founded | 1876 |
| Students | ~30,000 |
| Motto | Veritas vos liberabit (The truth shall make you free) |
| Website | [jhu.edu](https://www.jhu.edu) |

History

Johns Hopkins University was founded in 1876 by Johns Hopkins, a philanthropist who envisioned a research university that would combine advanced scholarship with practical education. The university opened its medical school in 1893, and the School of Medicine quickly became one of the nation's leading medical institutions.

Johns Hopkins has been a pioneer in neuroscience research throughout its history. The Johns Hopkins Alzheimer's Disease Research Center was established in 1984 as one of the original NIH-funded ADRCs, and the institution has continued to lead in neurodegeneration research. The institution has produced numerous landmark discoveries in understanding Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

Research Programs

Alzheimer's Disease Research Center (ADRC)

Founded in 1984, the Johns Hopkins ADRC is one of the original NIH-funded Alzheimer's Disease Research Centers. The center focuses on:

• Early Detection and Biomarkers - CSF, blood, and imaging biomarkers for preclinical AD
• Clinical Trials - Novel therapeutics including anti-amyloid, anti-[tau](/proteins/tau), and novel mechanisms
• Neuroimaging Advances - Amyloid and [tau](/proteins/tau) PET, structural and functional MRI
• Genetic Risk Factors - [APOE](/proteins/apoe-protein), [TREM2](/proteins/trem2-protein), and novel genetic risk variants
• Neuropathology - Brain banking, Lewy body and Alzheimer's pathology studies

Morris K. Udall Center

JHU houses a Udall Center of Excellence for Parkinson's Disease Research, focusing on:

• [Alpha-synuclein](/proteins/alpha-synuclein) Biology - Aggregation mechanisms, strain diversity, propagation
• LRRK2 Kinase Function - Pathogenic mutations, kinase inhibitors
• Dopaminergic [Neuron](/entities/neurons) Survival - Mechanisms of vulnerability and resilience
• Protein Degradation - [Autophagy](/entities/autophagy), [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system)

Center for Neurodegeneration and Repair

This interdisciplinary center brings together researchers from neurology, neuroscience, psychiatry, and engineering:

• Protein Misfolding and Aggregation - Amyloid, tau, [alpha-synuclein](/proteins/alpha-synuclein), [TDP-43](/proteins/tdp-43)
• Neuroinflammation - [Microglia](/entities/microglia), complement, peripheral immune interactions
• Neurovascular Dysfunction - [Blood-brain barrier](/entities/blood-brain-barrier), cerebral blood flow
• Computational Neuroscience - Machine learning for biomarker discovery

Center for Brain Health

A multidisciplinary center focused on:

• Cognitive Reserve - Building resilience to neurodegeneration
• Lifestyle Interventions - Exercise, diet, cognitive training
• Prevention Trials - Preclinical Alzheimer's intervention studies

Institute for Cell Engineering

Leading research in:

• Stem Cell Therapy - iPSC models of neurodegeneration
• Gene Therapy - AAV-delivered therapeutic proteins
• Regenerative Medicine - Cell replacement approaches

Key Researchers

• Dr. Juan Troncoso - Director of the ADRC, expert in Lewy body pathology and aging, neuropathology
• Dr. John Gear - Parkinson's disease researcher, LRRK2 biology, protein aggregation
• Dr. Marilyn Albert - Cognitive neuroscience, early detection biomarkers, clinical trials
• Dr. Rebecca Gottesman - Vascular contributions to cognitive impairment, stroke and dementia
• Dr. Oliver S. John - Statistical genetics, GWAS, polygenic risk scores
• Dr. Jeffrey Rothstein - ALS researcher, [TDP-43](/mechanisms/tdp-43-proteinopathy), glutamate excitotoxicity
• Dr. Philip Wong - [Tau](/proteins/tau) biology, protein aggregation mechanisms
• Dr. David Sullivan - Prion diseases, protein misfolding
• Dr. Guy M. McKhann - Alzheimer's disease clinical trials, cognitive assessment

Notable Discoveries

[TREM2](/genes/trem2) variants: JHU researchers contributed to discovering [TREM2](/proteins/trem2) risk variants for Alzheimer's disease (Guerreiro et al., 2013)

Lewy body pathology: Seminal work on the distribution and progression of Lewy bodies in Parkinson's disease (Troncoso et al.)

Biomarker development: Pioneering CSF and plasma biomarker studies for AD and PD

Neuroimaging advances: Development and validation of amyloid and tau PET imaging methods

LRRK2 biology: Discovery of LRRK2 mutations in Parkinson's disease

Tau propagation: Foundational work on tau oligomerization and spread

Facilities

• Johns Hopkins School of Medicine - Research hospitals and laboratories
• Brain Resource Center - Brain banking, postmortem tissue
• MRI Imaging Center - 3T and 7T MRI scanners
• PET Imaging Facility - Amyloid, tau, and FDG PET
• Stem Cell Core - iPSC derivation and differentiation
• Clinical Trials Unit - Phase I-III clinical trials

Training Programs

• MD/PhD Program - Combined medical and research training
• PhD in Neuroscience - Program in Cellular and Molecular Medicine
• Postdoctoral Fellowships - NIH-funded training positions
• Neurology Residency - ACGME-accredited training

Disease Focus

| Disease | Research Intensity |
|---------|-------------------|
| Alzheimer's Disease | Very High |
| Parkinson's Disease | Very High |
| Lewy Body Dementia | High |
| ALS | High |
| Frontotemporal Dementia | Moderate-High |
| Prion Diseases | Moderate |

Cross-Links

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Lewy Body Dementia](/diseases/dementia-lewy-bodies)
• [TREM2 Gene](/proteins/trem2-protein)
• [LRRK2 Protein](/proteins/lrrk2-protein)
• [Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-aggregation-pathway)
• [Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
• [Amyloid Cascade Pathway](/mechanisms/amyloid-cascade-pathway)

Background

The study of Johns Hopkins University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• National Institute on Aging
• University of Pennsylvania
• [Columbia University](/institutions/columbia-university)
• [Harvard Medical School](/institutions/harvard-medical-school)

External Links

• [Johns Hopkins University](https://www.jhu.edu)
• [Johns Hopkins School of Medicine](https://www.hopkinsmedicine.org)
• [Alzheimer's Disease Research Center](https://www.hopkinsadrc.org)
• [Morris K. Udall Center](https://www.hopkinsmedicine.org/neurology/udall-center)

References

Troncoso JC, et al, (2008) (2008)

Singleton A, et al, (2003) (2003)

Rebeck GW, et al, (2018) (2018)

Moghekar A, et al, (2012) (2012)

Guerreiro R, et al, (2013) (2013)

Chen-Plotkin AS, et al, (2018) (2018)

Unknown, Alzheimer's Disease Research Center Annual Reports 2020-2024 (2020)